• 1
    Tysk C, Lindberg E, Jarnerot G, Floderus-Myrhed B. Ulcerative colitis and Crohn’s disease in an unselected population of monozygotic and dizygotic twins. A study of heritability and the influence of smoking. Gut 1988; 29: 9906.
  • 2
    Rutgeerts P, Goboes K, Peeters M, et al. Effect of faecal stream diversion on recurrence of Crohn’s disease in the neoterminal ileum. Lancet 1991; 338: 7714.
  • 3
    Seksik P, Rigottier-Gois L, Gramet G, et al. Alterations of the dominant faecal bacterial groups in patients with Crohn’s disease of the colon. Gut 2003; 52: 23742.
  • 4
    Manichanh C, Rigottier-Gois L, Bonnaud E, et al. Reduced diversity of faecal microbiota in Crohn’s disease revealed by a metagenomic approach. Gut 2006;55:20511. Epub 2005 Sep 27.
  • 5
    Naser SA, Ghobrial G, Romero C, Valentine JF. Culture of Mycobacterium avium subspecies paratuberculosis from the blood of patients with Crohn’s disease. Lancet 2004; 364: 103944.
  • 6
    Ekbom A, Wakefield AJ, Zack M, Adami HO. Perinatal measles infection and subsequent Crohn’s disease. Lancet 1994; 344: 50810.
  • 7
    Liu Y, Van Kruiningen HJ, West AB, Cartun RW, Cortot A, Colombel JF. Immunocytochemical evidence of Listeria, Escherichia coli, and Streptococcus antigens in Crohn’s disease. Gastroenterology 1995; 108: 1396404.
  • 8
    Darfeuille-Michaud A, Boudeau J, Bulois P, et al. High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn’s disease. Gastroenterology 2004; 127: 41221.
  • 9
    Quinton JF, Sendid B, Reumaux D, et al. Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: prevalence and diagnostic role. Gut 1998; 42: 78891.
  • 10
    Standaert-Vitse A, Jouault T, Vandewalle P, et al. Candida albicans is an immunogen for anti-Saccharomyces cerevisiae antibody markers of Crohn’s disease. Gastroenterology 2006; 130: 176475.
  • 11
    Fox JG, Chien CC, Dewhirst FE, et al. Helicobacter canadensis sp. nov. isolated from humans with diarrhea as an example of an emerging pathogen. J Clin Microbiol 2000; 38: 25469.
  • 12
    Burnens AP, Stanley J, Schaad UB, Nicolet J. Novel Campylobacter-like organism resembling Helicobacter fennelliae isolated from a boy with gastroenteritis and from dogs. J Clin Microbiol 1993; 31: 19167.
  • 13
    Totten PA, Fennell CL, Tenover FC, et al. Campylobacter cinaedi (sp. nov.) and Campylobacter fennelliae (sp. nov.): two new Campylobacter species associated with enteric disease in homosexual men. J Infect Dis 1985; 151: 1319.
  • 14
    Stanley J, Linton D, Burnens AP, et al. Helicobacter pullorum sp. nov.-genotype and phenotype of a new species isolated from poultry and from human patients with gastroenteritis. Microbiology 1994; 140: 34419.
  • 15
    Romero S, Archer JR, Hamacher ME, Bologna SM, Schell RF. Case report of an unclassified microaerophilic bacterium associated with gastroenteritis. J Clin Microbiol 1988; 26: 1423.
  • 16
    Melito PL, Munro C, Chipman PR, Woodward DL, Booth TF, Rodgers FG. Helicobacter winghamensis sp. nov., a novel Helicobacter sp. isolated from patients with gastroenteritis. J Clin Microbiol 2001; 39: 24127.
  • 17
    Kullberg MC, Ward JM, Gorelick PL, et al. Helicobacter hepaticus triggers colitis in specific-pathogen-free interleukin-10 (IL-10)-deficient mice through an IL-12- and gamma interferon-dependent mechanism. Infect Immun 1998; 66: 515766.
  • 18
    Erdman S, Fox JG, Dangler CA, Feldman D, Horwitz BH. Typhlocolitis in NF-kappa B-deficient mice. J Immunol 2001; 166: 14437.
  • 19
    Burich A, Hershberg R, Waggie K, et al. Helicobacter-induced inflammatory bowel disease in IL-10- and T cell-deficient mice. Am J Physiol Gastrointest Liver Physiol 2001; 281: G76478.
  • 20
    Fox JG, Yan L, Shames B, Campbell J, Murphy JC, Li X. Persistent hepatitis and enterocolitis in germfree mice infected with Helicobacter hepaticus. Infect Immun 1996; 64: 367381.
  • 21
    Jergens AE, Wilson-Welder JH, Dorn A, et al. Helicobacter bilis triggers persistent immune reactivity to antigens derived from the commensal bacteria in gnotobiotic C3H/HeN mice. Gut 2007; 56: 93440.
  • 22
    Bell SJ, Chisholm SA, Owen RJ, Borriello SP, Kamm MA. Evaluation of Helicobacter species in inflammatory bowel disease. Aliment Pharmacol Ther 2003; 18: 4816.
  • 23
    Huijsdens XW, Linskens RK, Koppes J, et al. Detection of Helicobacter species DNA by quantitative PCR in the gastrointestinal tract of healthy individuals and of patients with inflammatory bowel disease. FEMS Immunol Med Microbiol 2004; 41: 7984.
  • 24
    Bohr UR, Glasbrenner B, Primus A, Zagoura A, Wex T, Malfertheiner P. Identification of enterohepatic Helicobacter species in patients suffering from inflammatory bowel disease. J Clin Microbiol 2004; 42: 27668.
  • 25
    Zhang L, Day A, McKenzie G, Mitchell H. Nongastric Helicobacter species detected in the intestinal tract of children. J Clin Microbiol 2006; 44: 22769.
  • 26
    Rutgeerts P, Geboes K, Vantrappen G, Beyls J, Kerremans R, Hiele M. Predictability of the postoperative course of Crohn’s disease. Gastroenterology 1990; 99: 95663.
  • 27
    Marteau P, Lemann M, Seksik P, et al. Ineffectiveness of Lactobacillus johnsonii LA1 for prophylaxis of postoperative recurrence in Crohn’s disease: a randomised, double blind, placebo controlled GETAID trial. Gut 2006; 55: 8427.
  • 28
    Tukel T, Shalata A, Present D, et al. Crohn disease: frequency and nature of CARD15 mutations in Ashkenazi and Sephardi/Oriental Jewish families. Am J Hum Genet 2004; 74: 62336.
  • 29
    Monteiro L, De Mascarel A, Sarrasqueta AM, et al. Diagnosis of Helicobacter pylori infection: noninvasive methods compared to invasive methods and evaluation of two new tests. Am J Gastroenterol 2001; 96: 3538.
    Direct Link:
  • 30
    Karmali MA, Simor AE, Roscoe M, Fleming PC, Smith SS, Lane J. Evaluation of a blood-free, charcoal-based, selective medium for the isolation of Campylobacter organisms from feces. J Clin Microbiol 1986; 23: 4569.
  • 31
    Occhialini A, Marais A, Urdaci M, et al. Composition and gene expression of the cag pathogenicity island in Helicobacter pylori strains isolated from gastric carcinoma and gastritis patients in Costa Rica. Infect Immun 2001; 69: 19028.
  • 32
    Rocha M, Avenaud P, Menard A, et al. Association of Helicobacter species with hepatitis C cirrhosis with or without hepatocellular carcinoma. Gut 2005; 54: 396401.
  • 33
    Fox JG, Dewhirst FE, Shen Z, et al. Hepatic Helicobacter species identified in bile and gallbladder tissue from Chileans with chronic cholecystitis. Gastroenterology 1998; 114: 75563.
  • 34
    Menard A, Santos A, Megraud F, Oleastro M. PCR-restriction fragment length polymorphism can also detect point mutation A2142C in the 23S rRNA gene, associated with Helicobacter pylori resistance to clarithromycin. Antimicrob Agents Chemother 2002; 46: 11567.
  • 35
    Boonjakuakul JK, Syvanen M, Suryaprasad A, Bowlus CL, Solnick JV. Transcription profile of Helicobacter pylori in the human stomach reflects its physiology in vivo. J Infect Dis 2004; 190: 94656.
  • 36
    He Q, Wang JP, Osato M, Lachman LB. Real-time quantitative PCR for detection of Helicobacter pylori. J Clin Microbiol 2002; 40: 37208.
  • 37
    Mikula M, Dzwonek A, Jagusztyn-Krynicka K, Ostrowski J. Quantitative detection for low levels of Helicobacter pylori infection in experimentally infected mice by real-time PCR. J Microbiol Methods 2003; 55: 3519.
  • 38
    Harper CG, Feng Y, Xu S, et al. Helicobacter cetorum sp. nov., a urease-positive Helicobacter species isolated from dolphins and whales. J Clin Microbiol 2002; 40: 453643.
  • 39
    Germani Y, Dauga C, Duval P, et al. Strategy for the detection of Helicobacter species by amplification of 16S rRNA genes and identification of H. felis in a human gastric biopsy. Res Microbiol 1997; 148: 31526.
  • 40
    Stalke P, Al-Soud WA, Bielawski KP, et al. Detection of Helicobacter species in liver and stomach tissues of patients with chronic liver diseases using polymerase chain reaction-denaturing gradient gel electrophoresis and immunohistochemistry. Scand J Gastroenterol 2005; 40: 103241.
  • 41
    Al-Soud WA, Bennedsen M, On SL, et al. Assessment of PCR-DGGE for the identification of diverse Helicobacter species, and application to faecal samples from zoo animals to determine Helicobacter prevalence. J Med Microbiol 2003; 52: 76571.
  • 42
    Satsangi J, Silverberg MS, Vermeire S, Colombel JF. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut 2006; 55: 74953.
  • 43
    Laharie D, Asensio C, Menard A, et al. Prévalence des Hélicobacters entéro-hépatiques dans la maladie de Crohn : étude préliminaire. Gastroenterol Clin Biol 2003; 27: A150.
  • 44
    Rothman KJ, Greenland S. Modern Epidemiology. Philadelphia: Lippincott-Raven eds, 1998.
  • 45
    Fox JG. The non-H pylori helicobacters: their expanding role in gastrointestinal and systemic diseases. Gut 2002; 50: 27383.
  • 46
    Rutgeerts P, Hiele M, Geboes K, et al. Controlled trial of metronidazole treatment for prevention of Crohn’s recurrence after ileal resection. Gastroenterology 1995; 108: 161721.
  • 47
    Alvarez-Lobos M, Arostegui JI, Sans M, et al. Crohn’s disease patients carrying Nod2/CARD15 gene variants have an increased and early need for first surgery due to stricturing disease and higher rate of surgical recurrence. Ann Surg 2005; 242: 693700.
  • 48
    Collins SM, Vallance B, Barbara G, Borgaonkar M. Putative inflammatory and immunological mechanisms in functional bowel disorders. Baillieres Best Pract Res Clin Gastroenterol 1999; 13: 42936.
  • 49
    Hugot JP, Zaccaria I, Cavanaugh J, et al. Prevalence of CARD15/NOD2 mutations in Caucasian healthy people. Am J Gastroenterol 2007; 102: 125967.
    Direct Link:
  • 50
    Ceelen LM, Decostere A, Van den Bulck K, et al. Helicobacter pullorum in chickens, Belgium. Emerg Infect Dis 2006; 12: 2637.
  • 51
    Burnens AP, Stanley J, Morgenstern R, Nicolet J. Gastroenteritis associated with Helicobacter pullorum. Lancet 1994; 344: 156970.
  • 52
    Ceelen L, Decostere A, Verschraegen G, Ducatelle R, Haesebrouck F. Prevalence of Helicobacter pullorum among patients with gastrointestinal disease and clinically healthy persons. J Clin Microbiol 2005; 43: 29846.
  • 53
    Young VB, Knox KA, Pratt JS, et al. In vitro and in vivo characterization of Helicobacter hepaticus cytolethal distending toxin mutants. Infect Immun 2004; 72: 25217.
  • 54
    Varon C, Duriez A, Lehours P, et al. Study of Helicobacter pullorum proinflammatory properties on human epithelial cells in vitro. Gut 2008; 58: 62935.
  • 55
    Viala J, Chaput C, Boneca IG, et al. Nod1 responds to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island. Nat Immunol 2004; 5: 116674.
  • 56
    Duerr RH, Taylor KD, Brant SR, et al. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 2006; 314: 14613.
  • 57
    Kullberg MC, Jankovic D, Feng CG, et al. IL-23 plays a key role in Helicobacter hepaticus-induced T cell-dependent colitis. J Exp Med 2006; 203: 248594.